Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
AMBS > SEC Filings for AMBS > Form 8-K on 31-Mar-2014All Recent SEC Filings

Show all filings for AMARANTUS BIOSCIENCE HOLDINGS, INC.

Form 8-K for AMARANTUS BIOSCIENCE HOLDINGS, INC.


31-Mar-2014

Regulation FD Disclosure, Other Events, Financial Statements


Item 7.01 Regulation FD Disclosure.

On March 31, 2014, Amarantus Bioscience Holdings, Inc.'s (the "Company") CEO, Gerald Commissiong, updated the status of commercialization of its LymPro TestŪ through a blog entry on the Company's Chairman's Blog . A copy of the blog entry is furnished as Exhibit 99.1 to this Current Report on Form 8-K.



Item 8.01 Other Events.

On March 31, 2014, the Company issued a press release announcing that Dr. Louis Kirby has been appointed to its Board of Advisors to assist the Company in the development and commercialization of the LymPro TestŪ for Alzheimer's disease.

The information disclosed under Item 7.01 and Item 8.01, including Exhibits 99.1 and 99.2 hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as expressly set forth in such filing.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit    Description
No.


99.1       Commercialization On-Track for 2014: Updating LymPro TestŪ Progress
           Blog Entry
99.2
           Press Release dated March 31, 2014

  Add AMBS to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for AMBS - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.